GLP2R
Glucagon-like peptide 2 receptor
Also known as: GLP2R_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95838
- Gene
- GLP2R
- Ensembl
- ENSG00000065325
- Chromosome
- 17
- Canonical length
- 553 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
This gene encodes a G protein-coupled receptor that is closely related to the glucagon receptor and binds to glucagon-like peptide-2 (GLP2). Signalling through GLP2 stimulates intestinal growth and increases villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. [provided by RefSeq, Dec 2014]
Canonical amino-acid sequenceUniProt
553 residues, UniProt reviewed canonical sequence.
>O95838|GLP2R
1 MKLGSSRAGP GRGSAGLLPG VHELPMGIPA PWGTSPLSFH RKCSLWAPGR PFLTLVLLVS
61 IKQVTGSLLE ETTRKWAQYK QACLRDLLKE PSGIFCNGTF DQYVCWPHSS PGNVSVPCPS
121 YLPWWSEESS GRAYRHCLAQ GTWQTIENAT DIWQDDSECS ENHSFKQNVD RYALLSTLQL
181 MYTVGYSFSL ISLFLALTLL LFLRKLHCTR NYIHMNLFAS FILRTLAVLV KDVVFYNSYS
241 KRPDNENGWM SYLSEMSTSC RSVQVLLHYF VGANYLWLLV EGLYLHTLLE PTVLPERRLW
301 PRYLLLGWAF PVLFVVPWGF ARAHLENTGC WTTNGNKKIW WIIRGPMMLC VTVNFFIFLK
361 ILKLLISKLK AHQMCFRDYK YRLAKSTLVL IPLLGVHEIL FSFITDDQVE GFAKLIRLFI
421 QLTLSSFHGF LVALQYGFAN GEVKAELRKY WVRFLLARHS GCRACVLGKD FRFLGKCPKK
481 LSEGDGAEKL RKLQPSLNSG RLLHLAMRGL GELGAQPQQD HARWPRGSSL SECSEGDVTM
541 ANTMEEILEE SEILocalizationUniProt · AlphaFold · HPA
Whether an antibody against GLP2R can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- colon: 13 nTPM
- urinary bladder: 12 nTPM
- gallbladder: 11 nTPM
- duodenum: 9.3 nTPM
- small intestine: 8.4 nTPM
- adipose tissue: 8.2 nTPM
Single-cell type
- rod photoreceptor cells: 59 nCPM
- cone photoreceptor cells: 21 nCPM
- fibro-adipogenic progenitors: 13 nCPM
- hepatic stellate cells: 13 nCPM
- leydig cells: 8.8 nCPM
- fibroblasts: 7.6 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 9.3 nTPM
- basal ganglia: 7.8 nTPM
- white matter: 5.6 nTPM
- hippocampal formation: 2.6 nTPM
- midbrain: 2.1 nTPM
- amygdala: 1.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.16
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-modulating G protein-coupled receptor signaling pathway
- cell surface receptor signaling pathway
- positive regulation of cell population proliferation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GPCR, family 2, secretin-like
- GPCR, family 2, extracellular hormone receptor domain
- GPCR, family 2-like, 7TM
- GPCR, family 2, secretin-like, conserved site
- GPCR family 2, extracellular hormone receptor domain superfamily
- G-protein coupled receptor 2
- 7 transmembrane receptor (Secretin family)
- Hormone receptor domain
- GPCR family 2, glucagon-like peptide 2 receptor, 7TM
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GLP2R as an antibody target. Whether an autoantibody or antibody against GLP2R could matter depends on whether native GLP2R is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GLP2R is annotated at the cell surface, where native GLP2R is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GLP2R as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...